IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 202 filers reported holding IMPAX LABORATORIES INC in Q4 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $60,000 | -42.9% | 3,096 | -50.9% | 0.00% | -100.0% |
| Q4 2017 | $105,000 | -25.0% | 6,307 | -8.7% | 0.00% | 0.0% |
| Q3 2017 | $140,000 | -36.9% | 6,911 | -50.0% | 0.00% | 0.0% |
| Q2 2017 | $222,000 | +184.6% | 13,822 | +125.4% | 0.00% | – |
| Q1 2017 | $78,000 | +34.5% | 6,131 | +51.3% | 0.00% | – |
| Q4 2016 | $58,000 | -96.6% | 4,052 | -94.3% | 0.00% | -100.0% |
| Q3 2016 | $1,694,000 | +28.3% | 71,497 | +56.1% | 0.01% | +11.1% |
| Q2 2016 | $1,320,000 | -9.3% | 45,803 | +0.7% | 0.01% | -10.0% |
| Q1 2016 | $1,456,000 | -30.9% | 45,480 | -7.6% | 0.01% | -23.1% |
| Q4 2015 | $2,106,000 | +34.4% | 49,247 | +10.7% | 0.01% | +30.0% |
| Q3 2015 | $1,567,000 | -40.6% | 44,497 | -22.6% | 0.01% | -33.3% |
| Q2 2015 | $2,640,000 | +0.7% | 57,497 | +2.8% | 0.02% | 0.0% |
| Q1 2015 | $2,622,000 | +18.8% | 55,939 | -19.7% | 0.02% | +15.4% |
| Q4 2014 | $2,207,000 | +24.3% | 69,663 | -6.9% | 0.01% | +30.0% |
| Q3 2014 | $1,775,000 | -22.4% | 74,857 | -1.8% | 0.01% | -23.1% |
| Q2 2014 | $2,287,000 | +13.7% | 76,251 | +0.1% | 0.01% | +8.3% |
| Q1 2014 | $2,012,000 | +0.6% | 76,148 | -4.3% | 0.01% | +9.1% |
| Q4 2013 | $2,000,000 | +2930.3% | 79,544 | +2361.9% | 0.01% | – |
| Q3 2013 | $66,000 | – | 3,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |